- Home
- TPST vs FEAM Comparison
TPST vs FEAM Comparison
Compare TPST & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- FEAM
- Stock Information
- Founded
- TPST 2011
- FEAM 2016
- Country
- TPST United States
- FEAM United States
- Employees
- TPST N/A
- FEAM N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- FEAM Major Chemicals
- Sector
- TPST Health Care
- FEAM Industrials
- Exchange
- TPST Nasdaq
- FEAM Nasdaq
- Market Cap
- TPST 27.2M
- FEAM 32.4M
- IPO Year
- TPST N/A
- FEAM N/A
- Fundamental
- Price
- TPST $0.70
- FEAM $0.49
- Analyst Decision
- TPST Strong Buy
- FEAM Strong Buy
- Analyst Count
- TPST 4
- FEAM 2
- Target Price
- TPST $20.00
- FEAM $5.63
- AVG Volume (30 Days)
- TPST 1.4M
- FEAM 70.9K
- Earning Date
- TPST 11-12-2024
- FEAM 02-12-2025
- Dividend Yield
- TPST N/A
- FEAM N/A
- EPS Growth
- TPST N/A
- FEAM N/A
- EPS
- TPST N/A
- FEAM N/A
- Revenue
- TPST N/A
- FEAM N/A
- Revenue This Year
- TPST N/A
- FEAM N/A
- Revenue Next Year
- TPST N/A
- FEAM $773.56
- P/E Ratio
- TPST N/A
- FEAM N/A
- Revenue Growth
- TPST N/A
- FEAM N/A
- 52 Week Low
- TPST $0.70
- FEAM $0.38
- 52 Week High
- TPST $6.00
- FEAM $2.48
- Technical
- Relative Strength Index (RSI)
- TPST 24.08
- FEAM 46.87
- Support Level
- TPST $0.86
- FEAM $0.40
- Resistance Level
- TPST $0.86
- FEAM $0.51
- Average True Range (ATR)
- TPST 0.07
- FEAM 0.06
- MACD
- TPST -0.01
- FEAM 0.00
- Stochastic Oscillator
- TPST 0.00
- FEAM 47.06
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.